You are here

Long-term use of AstraZeneca drug brings benefits, risks


LONG-TERM use of AstraZeneca's drug Brilinta can cut the risk of death, another heart attack or stroke in patients with a history of past attacks by 16 per cent, a keenly awaited clinical trial showed on Saturday.

The finding may boost sales of the blood-thinner, which

Market voices on:


Receive $80 Grab vouchers valid for use on all Grab services except GrabHitch and GrabShuttle when you subscribe to BT All-Digital at only $0.99*/month.

Find out more at

Powered by GET.comGetCom